Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
Premium Quality and Purity: Our glutathione supplements are manufactured to the highest pharmaceutical standards, ensuring maximum purity and potency
Vague pharmacy information: If the platform won't tell you which pharmacy fills the prescriptions, where the pharmacy is located, or what type of pharmacy it's, that's a red flag
Slow responders should evaluate at week 10 before adding stronger actives
Throughout the program, clients have meetings with our Nurse Practitioner to ensure their weight loss is safe and effective